Crinetics Pharmaceuticals Inc (CRNX)
EBITDA
-$508.79M
TTM · Period ending: · USD
CRNX EBITDA
Latest reported-$508.79Mperiod ending
Latest reported-$508.79Mperiod ending
CRNX TTM EBITDA (-$9.02M → -$508.79M)
TTM EBITDA
High-resolution chart · PNG
CRNX ebitda history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | EBITDA (USD) |
|---|---|
| -508,791,000 | |
| -492,083,000 | |
| -461,247,000 | |
| -419,413,000 | |
| -366,392,000 | |
| -325,016,000 | |
| -295,623,000 | |
| -275,651,000 | |
| -256,778,000 | |
| -234,175,000 | |
| -213,431,000 | |
| -198,307,000 | |
| -182,799,000 | |
| -174,260,000 | |
| -162,935,000 | |
| -148,783,000 | |
| -134,724,000 | |
| -118,429,000 | |
| -106,736,000 | |
| -97,743,000 | |
| -88,332,000 | |
| -79,152,000 | |
| -74,005,000 | |
| -67,424,000 | |
| -64,218,000 | |
| -60,648,000 | |
| -52,945,000 | |
| -46,247,000 | |
| -39,177,000 | |
| -31,669,000 | |
| -27,303,000 | |
| -21,488,000 | |
| -15,909,000 | |
| -11,922,000 | |
| -9,021,000 |